| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba045776bcd32d32e3100da8dfce4e28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
1990-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e087f04ff3d2f0cce518386c9cb89683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5d0824499ccd1054f2bf3e384054b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8911740a32aa6a750b2acf7dda847739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeaaedd740ef7c2db190f6feee29dd55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1993b44fd5eb8568adba6ad5d3ab0668 |
| publicationDate |
1993-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0399731-B1 |
| titleOfInvention |
Azaindenes |
| abstract |
The invention concerns azaindenes of the formula I <CHEM> (and their physiologically acceptable salts), together with pharmaceutical compositions containing them. The azaindenes antagonise the actions of angiotensin II and are of value in treating conditions such as hypertension and congestive heart failure. The invention further includes processes for the manufacture of the compounds and their use in medical treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6143743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6124463-A |
| priorityDate |
1989-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |